sublingually administered nitroglycerin appears to decrease left heart size , increase the velocity and extent of shortening in normal left ventricular segments and often reduce the extent of left ventricular wall motion abnormalities at rest and during isometric exercise in patients with previous transmural myocardial infarction .
C0017887
nitroglycerin
C0027051
myocardial infarction